key: cord-1041076-eqcqrz6w
authors: Nur, Erfan; Gaartman, Aafke E.; van Tuijn, Charlotte F. J.; Tang, Man Wai; Biemond, Bart J.
title: Vaso‐occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID‐19)
date: 2020-04-21
journal: Am J Hematol
DOI: 10.1002/ajh.25821
sha: f839fe136f825e10e702506d5d719a48eacbd239
doc_id: 1041076
cord_uid: eqcqrz6w

nan

In March 2020, during the 2019 novel coronavirus disease pandemic, caused by the newly emerged virus SARS-CoV-2, two patients with homozygous sickle cell disease (SCD) were admitted to our hospital with a painful vaso-occlusive crisis (VOC) triggered by COVID-19. Both patients had no flu-like complaints characteristic of COVID-19 during or preceding the VOC episode. 

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group

Acute chest syndrome in sickle cell disease due to the new influenza A (H1N1) virus infection

Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19)